Hudson Bay Capital Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Hudson Bay Capital Management’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-39,680	Closed	-$28.2K	–	1669
2025 Q4	$28.2K	Sell	39,680 -320	-0.8%	-$267	﹤0.01%	1124
2025 Q3	$34.8K	Hold	40,000	–	–	﹤0.01%	1155
2025 Q2	$35K	Sell	40,000 -50,000	-56%	-$38.6K	﹤0.01%	1276
2025 Q1	$67.5K	Buy	+90,000	New	+$68.4K	﹤0.01%	1178

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Hudson Bay Capital Management's OACCW Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) in Q1 2026, closing a stake of 39,680 shares — an estimated $28.2K sold.

Hudson Bay Capital Management first reported a position in OACCW in Q1 2025 and held it in 4 quarters. The position peaked at $67.5K in Q1 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

Hudson Bay Capital Management reported no remaining Oaktree Acquisition Corp III Life Sciences Warrant position as of Q1 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 39,680 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $28.2K.
Hudson Bay Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and held it in 4 quarters.
Hudson Bay Capital Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $67.5K in Q1 2025.
26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.